{"name":"Nina la Cour Freiesleben","slug":"nina-la-cour-freiesleben","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"\"Standard\" rFSH dose","genericName":"\"Standard\" rFSH dose","slug":"standard-rfsh-dose","indication":"Ovulation induction in women with anovulation or oligo-ovulation","status":"marketed"},{"name":"rFSH drug dose","genericName":"rFSH drug dose","slug":"rfsh-drug-dose","indication":"Infertility in women undergoing assisted reproductive technology (ART)","status":"marketed"}]}],"pipeline":[{"name":"\"Standard\" rFSH dose","genericName":"\"Standard\" rFSH dose","slug":"standard-rfsh-dose","phase":"marketed","mechanism":"Recombinant follicle-stimulating hormone (rFSH) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.","indications":["Ovulation induction in women with anovulation or oligo-ovulation","Controlled ovarian hyperstimulation in assisted reproductive technology (ART) cycles","In vitro fertilization (IVF)"],"catalyst":""},{"name":"rFSH drug dose","genericName":"rFSH drug dose","slug":"rfsh-drug-dose","phase":"marketed","mechanism":"rFSH (recombinant follicle-stimulating hormone) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.","indications":["Infertility in women undergoing assisted reproductive technology (ART)","Anovulation and ovulatory disorders in women"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1wZi1pSzlGZGY4RlBGRGw1WkZQY3ZJRGUyMVp0V0tYQXpDUFJNdTJsdDJvYUNfbkVZR1BnSjFoUkZFUzhKTGFSejR6UTE0RHhjSXZPRUNQNHVnWTA3REk4?oc=5","date":"2025-06-04","type":"trial","source":"Nature","summary":"Efficacy of clindamycin and LACTIN-V for in vitro fertilization patients with vaginal dysbiosis: a randomised double-blind, placebo-controlled multicentre trial - Nature","headline":"Efficacy of clindamycin and LACTIN-V for in vitro fertilization patients with vaginal dysbiosis: a randomised double-bli","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1qSnJzZUNVUmx4N0lnN3cza2ZqWE02VjBQOUhMcnROOG5CVld4ZEdhVWRGTGtETkMzSlRvRlJVdVRlN2FNTkpGZ21ycjNhVDJzaExfbHU5RzJUWjZJQVN3?oc=5","date":"2025-04-11","type":"trial","source":"Nature","summary":"IVF versus ICSI in patients without severe male factor infertility: a randomized clinical trial - Nature","headline":"IVF versus ICSI in patients without severe male factor infertility: a randomized clinical trial","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}